VivoSeq
Explore
Companies
Drugs
Sign In
Report Error
Fentanyl pectin
Phase 2
Small molecule
M
M.D. Anderson Cancer Center
1
Indications
3
Total Trials
0
Active Trials
0
Competitors
Clinical
Trials by Indication
[1]
Fentanyl
1 trial
Intranasal Fentanyl for Management of Pain Associated With Cystoscopic Procedures
Completed
·
R
Richard C Reznichek, MD
·
Phase 1
·
NCT01756651
·
20 enrolled
Clinical Trial
1 trial
PEctin Rapid Fentanyl Efficacy Clinical Trial For pAin at Swallowing Undergoing radioTherapy
Withdrawn
·
L
L.Molteni & C. dei F.lli Alitti-Soc. di Esercizio S.p.A.
·
Phase 3
·
NCT01980498
Dyspnea
1 trial
Fentanyl Pectin Nasal Spray (FNPS) for Exercise-Induced Breakthrough Dyspnea
Completed
·
M
M.D. Anderson Cancer Center
·
Phase 2
·
NCT01832402
·
35 enrolled
Sources
References
[1]
ClinicalTrials.gov
—
3 trial records for Fentanyl pectin. U.S. National Library of Medicine, National Institutes of Health.
[2]
ChEMBL
—
Fentanyl pectin compound record. European Bioinformatics Institute (EMBL-EBI).
[3]
Open Targets Platform
—
Drug–disease associations for Fentanyl pectin. EMBL-EBI & Wellcome Sanger Institute.
[4]
SEC EDGAR
—
M.D. Anderson Cancer Center company filings. U.S. Securities and Exchange Commission.
Details
Drug Info
Quick Facts
Modality
Small molecule
[2]
Highest Phase
Phase 2
[1]
Company
M
M.D. Anderson Cancer Center
Related News